OPTIMAL TUMOR REDUCTION, PLATINUM SENSITIVITY CHARACTERIZE LONG-TERM OVARIAN CANCER SURVIVAL
A multicenter study led by Tina’s Wish Researcher, Douglas Levine, MD, of MSK shows that women who are long-term survivors of high-grade… View more
PARADIGM SHIFT IN OVARIAN CANCER POINTS TO FALLOPIAN TUBE AS SITE OF ORIGIN
In an interview with Cancer Therapy Advisor, Dr. Ronny Drapkin, MD, PhD, the Franklin Payne Chair in Gynecologic Oncology and director of… View more
JUNIOR COMMITTEE TRIVIA NIGHT
Over 75 supporters gathered for the Tina’s Wish Junior Committee Trivia Night at Jack Doyle’s, NYC. Guests enjoyed appetizers, drink specials and… View more
OVARIAN CANCERS: EVOLVING PARADIGMS IN RESEARCH AND CARE
The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine Committee on the State of the Science in Ovarian… View more
LUNCH AND LEARN AT WHITE & CASE
Tina’s Wish hosted a Lunch & Learn at White & Case on March 1st to help educate employees on ovarian cancer and… View more
NANOTECHNOLOGY USES LIGHT TO SHOW DENSITY OF TUMORS
Tina’s Wish grant recipient, Daniel Heller, PhD, of Memorial Sloan Kettering Cancer Center discusses his use of nanotechnology to demonstrate tumor density.